ProShare Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,546
Closed -$9.08K 2146
2025
Q1
$9.08K Sell
10,546
-3,175
-23% -$4.72K ﹤0.01% 2070
2024
Q4
$23.1K Sell
13,721
-2,895
-17% -$6.92K ﹤0.01% 2252
2024
Q3
$47.4K Buy
16,616
+2,122
+15% +$5.49K ﹤0.01% 1986
2024
Q2
$33.9K Sell
14,494
-3,344
-19% -$8.73K ﹤0.01% 1782
2024
Q1
$52.4K Buy
17,838
+1,497
+9% +$4.25K ﹤0.01% 1898
2023
Q4
$48.9K Buy
16,341
+1,615
+11% +$4.62K ﹤0.01% 1864
2023
Q3
$46.5K Buy
14,726
+80
+0.5% +$260 ﹤0.01% 1722
2023
Q2
$56.7K Buy
14,646
+378
+3% +$1.09K ﹤0.01% 1759
2023
Q1
$39.5K Sell
14,268
-2,181
-13% -$4.58K ﹤0.01% 1690
2022
Q4
$29.6K Buy
16,449
+709
+5% +$1.37K ﹤0.01% 1785
2022
Q3
$33K Buy
15,740
+691
+5% +$1.74K ﹤0.01% 1694
2022
Q2
$40K Buy
15,049
+2,172
+17% +$8.08K ﹤0.01% 1728
2022
Q1
$56K Sell
12,877
-4,608
-26% -$18.9K ﹤0.01% 2107
2021
Q4
$91K Buy
+17,485
New +$93.6K ﹤0.01% 2217

Other funds holding NAUT